↓ Skip to main content

Cochrane Database of Systematic Reviews

Combination versus sequential single agent chemotherapy for metastatic breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
twitter
15 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
264 Mendeley
Title
Combination versus sequential single agent chemotherapy for metastatic breast cancer
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd008792.pub2
Pubmed ID
Authors

Rachel F Dear, Kevin McGeechan, Marisa C Jenkins, Alexandra Barratt, Martin HN Tattersall, Nicholas Wilcken

Abstract

Combination chemotherapy can cause greater tumour cell kill if the drug dose is not compromised, while sequential single agent chemotherapy may allow for greater dose intensity and treatment time, potentially meaning greater benefit from each single agent. In addition, sequentially using single agents might cause less toxicity and impairment of quality of life, but it is not known whether this might compromise survival time.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 264 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 2%
United Kingdom 2 <1%
Netherlands 1 <1%
Mexico 1 <1%
Japan 1 <1%
Colombia 1 <1%
Unknown 254 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 46 17%
Researcher 37 14%
Student > Master 30 11%
Student > Bachelor 28 11%
Other 24 9%
Other 46 17%
Unknown 53 20%
Readers by discipline Count As %
Medicine and Dentistry 91 34%
Agricultural and Biological Sciences 36 14%
Biochemistry, Genetics and Molecular Biology 23 9%
Chemistry 10 4%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Other 40 15%
Unknown 54 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2020.
All research outputs
#1,154,952
of 17,366,233 outputs
Outputs from Cochrane database of systematic reviews
#2,985
of 11,660 outputs
Outputs of similar age
#18,024
of 272,534 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 140 outputs
Altmetric has tracked 17,366,233 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,534 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.